Immune Design Corp. (IMDZ) insider have most recently took part in a trading activity. On Jan 8, 2018 Guthart Leo, 10% Owner bought 20,000 shares having total worth of $78,000 at the price of $3.9 per share, following the transaction a total of 5,664,739 shares owned by Guthart Leo. Before this latest buy, Guthart Leo purchased IMDZ at 5 other times during the past twelve months, for a total investment of $106.2M at an average of $6.13 per share.
The stock has experienced a total of 15 insider trades in the past three months. These trades include 6 sell activities and 9 buy trades. Furthermore, over the past 12 months , the stock was traded 20 times by insiders. In 7 of these trades, the insider was a seller while an employee of the company was the buyer in 13 instances.
|Time Frame||Number of Insider Buy||Number of Insider Sell||Stock Price Change(%)|
Shares of Immune Design Corp. (IMDZ) traded up 2.53% on Jan 4, 2018, hitting $4.05. 302,041 shares of the company’s stock traded hands. Immune Design Corp. has a 52 week low of $3.58 and a 52 week high of $12.3. The company’s market cap is $158 million.
Immune Design Corp. (IMDZ) last announced its earnings results on Nov 1, 2017. The company reported -0.52 earnings per share (EPS) for the quarter, higher than the consensus estimate of -0.63 by $0.11. The company had revenue of $1 million for the quarter, compared to the consensus estimate of $1 million. During the same quarter in the previous year, the company posted -0.60 earnings per share. The company’s revenue for the quarter was down 94% on a year-over-year basis.
|earnings per share||-0.52||-0.54||-0.50||-0.57||-0.60||-0.71||-0.61||-0.60||-0.37||-0.54|
Latest posts by William White (see all)
- Insider Trading Review: FS Investment Corporation $FSIC - January 13, 2018
- Insider Trader Watch: ENERTOPIA CORP $ENRT - January 13, 2018
- Insider Trading in Focus: Swiss Helvetia Fund, Inc. (The) $SWZ - January 13, 2018